🇺🇸 FDA
Patent

US 10081659

Adeno-associated vectors for enhanced transduction and reduced immunogenicity

granted A61KA61K48/0008A61K48/0075

Quick answer

US patent 10081659 (Adeno-associated vectors for enhanced transduction and reduced immunogenicity) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary, Dept. of Health and Human Services
Grant date
Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K48/0008, A61K48/0075